Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: The MILLENNIALS Study.
Hood ThabitJoshi Navis PrabhuWomba MubitaCatherine FullwoodShazli AzmiAndrea UrwinIan DoughtyLalantha LeelarathnaPublished in: Diabetes care (2020)
CGM use in young people with type 1 diabetes improves time in target and HbA1c levels compared with SMBG.
Keyphrases